The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice

Neuroscience Letters

Volumn 509, Issue 2, 2012, Pages 69-71

  Chen, Zhijun ^a   He, Ying ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Allodynia; Beta Lactam antibiotic; Ceftriaxone; GLT 1; Hyperalgesia; Opioid

Indexed keywords

CEFTRIAXONE; MORPHINE SULFATE; SODIUM CHLORIDE; VESICULAR GLUTAMATE TRANSPORTER 1;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INDUCED DISEASE; HYPERALGESIA; MALE; MOUSE; NONHUMAN; NOTE; OPIOID INDUCED HYPERALGESIA; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; UPREGULATION;

ANALGESICS, OPIOID; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEFTRIAXONE; DOWN-REGULATION; EXCITATORY AMINO ACID TRANSPORTER 2; HYPERALGESIA; MALE; MICE; MICE, INBRED ICR; MORPHINE; SPINAL CORD; UP-REGULATION;

EID: 84862831109     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.029     Document Type: Note

References (27)

1. Arriza J.L., Eliasof S., Kavanaugh M.P., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4155-4160.
2. 2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice. J. Pharmacol. Exp. Ther. 2009, 330:650-659.
3. 2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. J. Neurosci. 2010, 30:38-46.
4. Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain 2008, 24:479-496.
5. Fairman W.A., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., Amara S.G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995, 375:599-603.
6. Hu Y., Li W., Lu L., Cai J., Xian X., Zhang M., Li Q., Li L. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain 2010, 148:284-301.
7. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992, 360:467-471.
8. Katagiri H., Tanaka K., Manabe T. Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur. J. Neurosci. 2001, 14:547-553.
9. Knackstedt L.A., LaRowe S., Mardikian P., Malcolm R., Upadhyaya H., Hedden S., Markou A., Kalivas P.W. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol. Psychiatry 2009, 65:841-845.
10. Knackstedt L.A., Melendez R.I., Kalivas P.W. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol. Psychiatry 2010, 67:81-84.
11. Liang D.Y., Liao G., Wang J., Usuka J., Guo Y., Peltz G., Clark J.D. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 2006, 104:1054-1062.
12. 2+/calmodulin-dependent protein kinase II. J. Pharmacol. Exp. Ther. 2008, 325:267-275.
13. Maeda S., Kawamoto A., Yatani Y., Shirakawa H., Nakagawa T., Kaneko S. Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol. Pain 2008, 4:65.
14. Ozawa T., Nakagawa T., Sekiya Y., Minami M., Satoh M. Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur. J. Neurosci. 2004, 19:221-226.
15. Ozawa T., Nakagawa T., Shige K., Minami M., Satoh M. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 2001, 905:254-258.
16. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992, 360:464-467.
17. Rawls S.M., Baron D.A., Kim J. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behav. Pharmacol. 2010, 21:161-164.
18. Rawls S.M., Zielinski M., Patel H., Sacavage S., Baron D.A., Patel D. beta-Lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend. 2010, 107:261-263.
19. Reissner K.J., Kalivas P.W. Using glutamate homeostasis as a target for treating addictive disorders. Behav. Pharmacol. 2010, 21:514-522.
20. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
21. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. beta-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
22. Sari Y., Smith K.D., Ali P.K., Rebec G.V. Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J. Neurosci. 2009, 29:9239-9243.
23. Storck T., Schulte S., Hofmann K., Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10955-10959.
24. Sung B., Lim G., Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci. 2003, 23:2899-2910.
25. Tai Y.H., Wang Y.H., Wang J.J., Tao P.L., Tung C.S., Wong C.S. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain 2006, 124:77-86.
26. Tang L., Shukla P.K., Wang L.X., Wang Z.J. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J. Pharmacol. Exp. Ther. 2006, 317:901-909.
27. Tawfik V.L., Regan M.R., Haenggeli C., Lacroix-Fralish M.L., Nutile-McMenemy N., Perez N., Rothstein J.D., DeLeo J.A. Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 2008, 152:1086-1092.